FRDEEN
Swiss Medtech
For a strong Swiss medtech industry
SWISS MEDTECH was established on 12 June 2017 following the merger of two national medtech organizations, FASMED and Medical Cluster. The new association represents the interests of the Swiss medtech industry. The aim is to maintain international competitiveness, innovative capacity, and to strengthen the domestic market.
Image source: BVMed
Image source: BVMed

Whether it be syringes, implants, wheelchairs, or MRIs - medical technology supplies people, doctors, and hospitals with vital products and applications. The domestic medtech industry generates annual sales of 14.1 billion and exports of 10.6 billion Swiss francs. It contributes 2.2% of the GDP. Swiss Medtech supports the Swiss medtech industry's continuing contribution to health care and the economy, as well as its ability to remain competitive internationally.

The Association represents the interests of the industry and serves 1,350 companies and 54,500 employees. It is committed to rapid patient access to innovation and high-quality standards. Swiss Medtech also initiates specialised training programmes, challenges rising levels of regulation, and pushes for free trade and fair tariffs. Together with its specialist groups and partners, the Association is committed to favourable conditions and to an attractive setting for research and other professional activities within Switzerland.

More in "About Us"
News

Swiss Medtech Award 2018: An armband sensor to help women conceive

12.6.18 – Ava AG has won the Swiss Medtech Award at Swiss Medtech Day in Bern. The Zurich start-up was honoured for developing a fertility tracker which helps women who wish to have children recognize which are their fertile days each month.
 

State Councillor Beat Vonlanthen appointed president of Swiss Medtech

11.6.18 – He succeeds former National Councillor Urs Gasche and Rubino Mordasini, who shared the co-presidency. Following the merger of FASMED and Medical Cluster, Swiss Medtech is pleased to have 560 members. At its annual meeting the association looked back on a thoroughly positive first year.
 

Swiss Medtech Award: nominees with groundbreaking innovations
27.5.18 – Two start-ups from Zurich and one established Basel-based company have been nominated for the first prize of CHF 50,000: AVA, Xeltis and Bühlmann Laboratories have all developed pioneering medical products with significant patient benefits. These novel technologies also contribute to increased cost efficiency.
 

Swiss Medtech Day in Bern on 12 June 2018: The highlights

30.4.18 – The Swiss Medtech Association and its partner Innosuisse are hosting the largest medtech event in Switzerland for the first time - and are expecting over 600 participants. In addition to specialist lectures, breakout sessions and a Science Slam, the main attraction will be the presentation of the Swiss Medtech Awards.

 

Prepare yourself in time for the consequences of Brexit
12.4.18 – 30% to 40% of EU medical device market authorisations have received CE marks in the UK. These products may no longer be recognized following Brexit and the MDR transition period. Recertifications could also be delayed. A checklist compiled by Medtech Europe helps affected companies prepare for these scenarios.

 

Consequences of the new medical device regulations for health care in Switzerland?

28.3.18 – For many medtech companies, the time period granted for the necessary adaptations until 2020 will probably be insufficient, and certain products may become unavailable. At the MDR/IVDR conference of Swiss Medtech and the SVDI representatives of industry and authorities will discuss possible solutions and cooperation models.

 

⇒ More News ⇒ Media releases